Dizal Pharmaceutical develops innovative medicines for cancer and immune diseases. Its products and services include prescription drugs, clinical development, and commercialization for hospitals, doctors, and patients.
Dizal Pharmaceutical products and services overview:
Revenue: ~$50 million
Employees: 900
Headquarters: Shanghai, China
Dizal Pharmaceutical is one of the...
Dizal Pharmaceutical is a company listed under the stock ticker 688192 (CN).
View the org chart displaying its 16 main executives
Create your alert
to follow the executive moves at Dizal Pharmaceutical.
Dizal Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.